• Vt. to get $1.1 million drug settlement
    November 17,2012
     

    MONTPELIER — Vermont’s attorney general says the state will receive $1.1 million as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company deceptively marketed a diabetes drug.

    The complaint accuses GlaxoSmithKline LLC of engaging in unfair and deceptive practices by misrepresenting Avandia’s cardiovascular risks and safety profile.

    Vermont Attorney General William Sorrell said Thursday that GlaxoSmithKline has reached a $90 million settlement with 37 other attorneys general and has agreed to change how it markets and promotes diabetes drugs.

    MORE IN This Just In
    WHITE RIVER JUNCTION — Greg Smith, accused of shooting a man to death in downtown Springfield in... Full Story
    BERLIN — Vermont Fire Safety Director Michael Desrochers and other fire officials are encouraging... Full Story
    WILLISTON — Vermont State Police say they are ramping up enforcement efforts to nab drunken... Full Story
    More Articles
  •  
     
    • MEDIA GALLERY 
    • VIDEOS
    • PHOTOS